Current filters:

Drotrecogin alfa

1 to 9 of 44 results

FDA reacts to worries about Lilly's Xigris


The US Food and Drug Administration says it is working with Eli Lilly to further evaluate the incidence…

Drotrecogin alfaLillyXigris

Eight drugs get nod from EMEA's COMP


At its early July meeting, the Committee for Orphan Medicinal Products (COMP) of the European Medicines…

Antihemophilic FactorAsparaginaseCoagulation Factor VIIaDrotrecogin alfaElsparGlaxoSmithKlineGSKLevaquinLevofloxacinRecombinantXigris

Jury awards Ariad $65M damages in patent dispute with Lilly


A jury in the US District Court of Massachusetts in Boston has issued an initial decision in the case…

Ariad PharmaceuticalsDrotrecogin alfaEvistaLillyRaloxifeneXigris

Report sees "fundamental flaws" in many Rx studies; urges


Merck & Co's COX-2 inhibitor arthritis drug Vioxx (rofecoxib) eased the pain of millions of arthritis…

Drotrecogin alfaLillyMerck KGaARofecoxibVioxxXigris

Eli Lilly's income up 6% for 3rd-qtr 2004


USA-based drug major Eli Lilly has posted a 6% rise in net income to $755.2 million, or $0.69 per share,...

Atomoxetine HClDrotrecogin alfagemcitabine HclGemzarLillyOlanzapineStratteraXigrisZyprexa

1 to 9 of 44 results

Back to top